Old Drug, New Data: Broadening the Therapeutic Armamentarium for Desmoid Tumors

View at publisher Summarise with VIRAT
Authors: Fahima Dossa, Silvia Stacchiotti, Alessandro Gronchi
Cited by: 0
References: 5

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Desmoid tumors are a locally invasive neoplasm that can exhibit unpredictable clinical behavior. Although treatment options are numerous, few are supported by level 1 evidence. A recent phase III trial evaluated the efficacy of long-used pegylated liposomal doxorubicin in patients with progressive desmoid tumors. See related article by Xu et al., p. 2198.

Fields of Study & Subjects

Soft tissue tumor case studies Sarcoma Diagnosis and Treatment Neurofibromatosis and Schwannoma Cases

Publication details

Journal / source
Clinical Cancer Research
Volume
32
Issue
11
Pages
2127–2129
Publication date
27 March 2026
Language
EN